Sign in

CIK 0001802369 · <br>Emerging growth company

ADARx Pharmaceuticals, Inc.

Sign in to watch
Ticker
ADRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
844145188
Phone
858-283-9472
Business address
5871 OBERLIN DRIVE, SUITE 200, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$87,745,772
in 5 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$87,745,772. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-28 George Simeon Director Conversion +1,667,468 1,667,468
2026-09-28 George Simeon Director Conversion +169,001 1,836,469
2026-09-28 George Simeon Director Purchase +592,593 $17.00 $10.1M 592,593
2026-09-28 George Simeon Director Conversion · Series B Preferred Stock −3,907,547 0
2026-09-28 George Simeon Director Conversion · Series B-1 Preferred Stock −1,304,883 0
2026-09-28 George Simeon Director Conversion · Series C Preferred Stock −600,962 0
2026-09-28 George Simeon Director Conversion · Series C Preferred Stock −1,802,885 0
2026-09-28 George Simeon Director Conversion · Series B Preferred Stock −1,953,773 0
2026-09-28 George Simeon Director Conversion · Series B-1 Preferred Stock −198,019 0
2026-09-24 MacLeod Alan Robert Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +170,692 170,692
2026-09-24 Zhu Rui (NMN) Chief Technology Officer Grant or award · Employee Stock Option (right to buy) +512,076 512,076
2026-09-24 Ackles Robert William Chief People Officer Grant or award · Employee Stock Option (right to buy) +85,346 85,346
2026-09-24 Fisk Ryan CFO and CBO Grant or award · Employee Stock Option (right to buy) +170,692 170,692
2026-09-24 Li Zhen President and CEO Grant or award · Employee Stock Option (right to buy) +1,024,152 1,024,152

Page 5 of 5 · 94 trades